High ratios of free to total insulin-like growth factor-I in early infancy

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 1, 1997, Pages 156-158

  Hasegawa, Yukihiro ^a   Hasegawa, Tomonobu ^c   Fujii, Katsura ^a   Konii, Hideko ^a   Anzo, Makoto ^a   Aso, Taiji ^a   Koto, Shinobu ^a   Takada, Makoto ^b   Tsuchiya, Yutaka ^c  

^a Div of Endocrinology and Metabolism   (Japan)

^b Research Center   (Japan)

^c KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BODY GROWTH; CHILD; DENSITOMETRY; FEMALE; FETUS GROWTH; HUMAN; IMMUNOBLOTTING; IMMUNORADIOMETRIC ASSAY; INFANCY; MAJOR CLINICAL STUDY; MALE; METABOLISM; NEWBORN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0031017028     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.1.3679     Document Type: Article

References (14)

1. Jones JI, Clemmons DR. 1995 Insulin-like growth factors, and their binding proteins: biological actions. Endocr Rev. 16:3-34.
2. Cohen P, Fielder PJ, Hasegawa Y, Frisch H, Giudice LC, Rosenfeld RG. 1991 Clinical aspects of insulin-like growth factor binding proteins. Acta Endocrinol (Copenh). 124:74-85.
3. Takada M, Nakanome H, Koshida M, Hirose S, Hasegawa T, Hasegawa Y. 1994 Measurements of free IGF-I using immunoradiometric assay. J Immunoassay. 15:263-276.
4. Hasegawa Y, Takada M, Hasegawa T, Tsuchiya Y. 1996 Clinical utility of newly developed free insulin-like growth factor-I measurements in the diagnosis of growth hormone deficiency. Eur J Endocrinol. 134:184-189.
5. Hasegawa T, Hasegawa Y, Takada M, Tsuchiya Y. 1995 The free form of insulin-like growth factor-I increases in circulation during normal human pregnancy. J Clin Endocrinol Metab. 80:3284-3286.
6. Fielder PJ, Thordarson G, Talamates F, Rosenfeld RG. 1990 Characterization of insulin-like growth factor binding proteins (IGFBI's) during gestation in mice: effects of hypophysectomy and an IGFBP-specific serum protease activity. Endocrinology. 127:2270-2280.
7. Guidice LC, Farrell EM, Pham H, Lamson G, Rosenfeld RG. 1990 Insulin-like growth factor binding proteins in maternal serum throughout gestation, and on the puerperium: effects of a pregnancy-associated serum protease activity. J Clin Endocrinol Metab. 71:806-816.
8. Hosselopp P, Segovia B, Lassarre C, Roghani M, Bredon M, Binoux M. 1990 Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy. J Clin Endocrinol Metab. 71:797-805.
9. Hasegawa Y, Hasegawa T, Konii N, et al. 1995 Proteolytic activity of IGFBP-3 in various clinical conditions during childhood using western immunoblot technique. Endocrine J. 42:569-576.
10. Hasegawa Y, Hasegawa T, Konii H, Tsuchiya Y. 1995 Correlation between IGFBP-3 proteolytic activity and the ratio of free IGF-I to total IGF-I levels in circulation. Clin Endocrinol (Oxf). 43:943-945 (in Japanese).
11. Guler HP, Zapf J, Schmid C, Froesch ER. 1989 Insulin-like growth factors I and II in healthy man. Estimates of half lives and production rates. Acta Endocrinol (Copenh). 121:753-758.
12. Bagley CJ, May BL, Szabo L, et al. 1987 A key functional role for the insulin-like growth factor I N-terminal pentapeptide. Biochem J. 259:665-671.
13. Ballard FJ, Francis GL, Ross M, Bagley CJ, May BL, Wallace JC. 1987 Natural and synthetic forms of insulin-like growth factor-I (IGF-I) and the potent derivative, destripeptide IGF-I: biological activities and receptor binding. Biochem Biophys Res Commun. 149:398-404.
14. Yamamoto H, Murphy LJ. 1994 Generation of des-(1-3) Insulin-like growth factor-I in serum by an acid protease. Endocrinology. 135:2432-2439.